No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Today’s Diabetes Hits Different This American Diabetes Month For Over 133M Americans Living with Prediabetes and Diabetes

Editor: What To Know

  • Throughout the month, the ADA will elevate the different ways diabetes affects people's lives through storytelling and highlight the advancements in diabetes technology and treatments.
  • The ADA is thankful to our proud supporters, CVS Health® and WW for collaborating with us as we highlight how Today's Diabetes Hits Different during national diabetes awareness month.
  • We have new technologies and research leading to better diabetes management, education resources, and a community that's stronger than ever,” said Charles D.

The American Diabetes Association® (ADA), the world’s leading diabetes organization, today unveiled this November’s American Diabetes Month® theme to showcase how Today’s Diabetes Hits Different.

Throughout the month, the ADA will elevate the different ways diabetes affects people’s lives through storytelling and highlight the advancements in diabetes technology and treatments.

Many people living with prediabetes or diabetes experience an initial shock after their diagnosis—they worry about costs and care. They wonder how day-to-day life will change and how to manage their new condition—learning about risk factors and complications, building their support community. To bring education, assistance, and advocacy to these communities and their loved ones, ADA’s American Diabetes Month campaign focuses on these actions:

“In 2022 there are different ways to hit back. We have new technologies and research leading to better diabetes management, education resources, and a community that’s stronger than ever,” said Charles D. Henderson, CEO of the ADA. “We won’t stop fighting until we see a world free of diabetes and its burdens.”

The ADA is thankful to our proud supporters, CVS Health® and WW for collaborating with us as we highlight how Today’s Diabetes Hits Different during national diabetes awareness month.

Visit diabetes.org/HitsDifferent to learn more and share your story on social using #hitsdifferent.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy